Home › Grants › United States › Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
This Notice of Funding Opportunity (NOFO) invites applications from eligible academic and research institutions to apply for funding to modernize existing or construct new biomedical research facilities.
Grant (non-repayable) Intake closed; program continues (check for next intake)
- Funder
- National Institutes of Health
Funder profile and all of its programs - Amount
- Up to $8,000,000 per award (published on Grants.gov for the latest cycle).
- Where
- United States (federal)
- Eligibility
- Open to nonprofits and colleges, universities, schools or research institutions. Cost sharing or matching funds are required. Recurring: posted in 6 different years; this cycle has closed, watch for the next one.
- Sectors
- Education and training, Health and life sciences, Nonprofits and charities, Research and science, Transportation and infrastructure
- Deadline
- Varies: check the official page for current dates
- Source
- Grants.gov XML extract (PAR-25-061)
- Last checked
- 2 November 2026
- Funder contacts
- Public organizational contacts on file Unlock full profile / Sign up
From official open data: listed in the official Grants.gov extract on 2026-11-02. The summary is from the official listing; the eligibility line is our plain-language reading of its eligibility codes. Confirm details on the official page.
Related grant lists
Education and training Health and life sciences Nonprofits and charities Schools, colleges and research institutions Nonprofits and charities United States United States (national) Federal agency $1 million or more
Full eligibility results and funder contacts come with Pro and Lifetime, coming soon.
Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.